JP2016502527A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016502527A5 JP2016502527A5 JP2015542832A JP2015542832A JP2016502527A5 JP 2016502527 A5 JP2016502527 A5 JP 2016502527A5 JP 2015542832 A JP2015542832 A JP 2015542832A JP 2015542832 A JP2015542832 A JP 2015542832A JP 2016502527 A5 JP2016502527 A5 JP 2016502527A5
- Authority
- JP
- Japan
- Prior art keywords
- mir
- hsa
- composition
- mirna
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261727481P | 2012-11-16 | 2012-11-16 | |
| US61/727,481 | 2012-11-16 | ||
| PCT/US2013/070350 WO2014078686A1 (en) | 2012-11-16 | 2013-11-15 | Mirnas as novel therapeutic adjuvants and biomarkers for the prognosis and treatment of drug resistant breast cancers |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016502527A JP2016502527A (ja) | 2016-01-28 |
| JP2016502527A5 true JP2016502527A5 (enExample) | 2016-12-28 |
| JP6478916B2 JP6478916B2 (ja) | 2019-03-06 |
Family
ID=50731724
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015542832A Expired - Fee Related JP6478916B2 (ja) | 2012-11-16 | 2013-11-15 | 薬物耐性乳癌の予後判定および処置のための治療アジュバントおよびバイオマーカーとしてのｍｉＲＮＡ |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US9730954B2 (enExample) |
| EP (1) | EP2919817A4 (enExample) |
| JP (1) | JP6478916B2 (enExample) |
| CN (1) | CN104884097B (enExample) |
| CA (1) | CA2930795A1 (enExample) |
| WO (1) | WO2014078686A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016137235A2 (ko) | 2015-02-25 | 2016-09-01 | (주)바이오니아 | 마이크로 rna를 유효 성분으로 포함하는 암 치료용 약학 조성물 |
| CN106148538B (zh) * | 2016-08-09 | 2019-10-22 | 山东大学 | microRNA标志物组及其在制备评价乳腺癌化疗敏感性试剂盒中的应用 |
| CN107970254A (zh) * | 2017-12-08 | 2018-05-01 | 新乡医学院第附属医院 | miR-204及其靶基因在诊断和治疗骨肉瘤中的应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103866018B (zh) * | 2005-08-01 | 2016-05-25 | 俄亥俄州立大学研究基金会 | 用于乳腺癌的诊断、预后和治疗的基于MicroRNA的方法和组合物 |
| CA2717030A1 (en) * | 2008-02-28 | 2009-09-03 | The Ohio State University Research Foundation | Microrna signatures associated with cytogenetics and prognosis in acute myeloid leukemia (aml) and uses thereof |
| CN102076853A (zh) * | 2008-05-07 | 2011-05-25 | 阿布拉西斯生物科学有限责任公司 | 通过miRNA增强药物疗法 |
| EP2354246A1 (en) | 2010-02-05 | 2011-08-10 | febit holding GmbH | miRNA in the diagnosis of ovarian cancer |
-
2013
- 2013-11-15 US US14/442,896 patent/US9730954B2/en not_active Expired - Fee Related
- 2013-11-15 WO PCT/US2013/070350 patent/WO2014078686A1/en not_active Ceased
- 2013-11-15 CA CA2930795A patent/CA2930795A1/en not_active Abandoned
- 2013-11-15 CN CN201380065778.4A patent/CN104884097B/zh not_active Expired - Fee Related
- 2013-11-15 JP JP2015542832A patent/JP6478916B2/ja not_active Expired - Fee Related
- 2013-11-15 EP EP13854326.9A patent/EP2919817A4/en not_active Withdrawn
-
2017
- 2017-08-14 US US15/675,877 patent/US10617709B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2018233032B2 (en) | TEC family kinase inhibitor adjuvant therapy | |
| Li et al. | Stem cell quiescence | |
| Yi et al. | A Hybrid Nanoadjuvant Simultaneously Depresses PD‐L1/TGF‐β1 and Activates cGAS‐STING Pathway to Overcome Radio‐Immunotherapy Resistance | |
| Meng et al. | Targeting aerobic glycolysis by dichloroacetate improves Newcastle disease virus-mediated viro-immunotherapy in hepatocellular carcinoma | |
| Khandelwal et al. | Ruxolitinib as salvage therapy in steroid-refractory acute graft-versus-host disease in pediatric hematopoietic stem cell transplant patients | |
| Hu et al. | Nanodrugs incorporating LDHA siRNA inhibit M2-like polarization of TAMs and amplify autophagy to assist oxaliplatin chemotherapy against colorectal cancer | |
| KR20160066554A (ko) | 브루톤 타이로신 키나제 억제제 및 면역요법을 이용한 치료 | |
| CN110934873B (zh) | 靶向组织微环境中衰老细胞的抗衰老药物d/s及其应用 | |
| Toro et al. | New therapeutic perspectives in the treatment of uveal melanoma: a systematic review | |
| Ye et al. | GZD824 suppresses the growth of human B cell precursor acute lymphoblastic leukemia cells by inhibiting the SRC kinase and PI3K/AKT pathways | |
| Carew et al. | Oncolytic reovirus inhibits angiogenesis through induction of CXCL10/IP-10 and abrogation of HIF activity in soft tissue sarcomas | |
| CN106488766A (zh) | 利用氧气疗法的分割放疗和化疗 | |
| AU2020322440A2 (en) | Compositions and methods of using C/EBP alpha saRNA | |
| Jin et al. | Different origin-derived exosomes and their clinical advantages in cancer therapy | |
| Zhou et al. | Tellurium/bovine serum albumin nanocomposites inducing the formation of stress granules in a protein kinase R-dependent manner | |
| Synoradzki et al. | From molecular biology to novel immunotherapies and nanomedicine in uveal melanoma | |
| JP2016502527A5 (enExample) | ||
| JP2009510165A5 (enExample) | ||
| Farhangfar et al. | In vivo study of anticancer activity of ginsenoside Rh2-containing arginine-reduced graphene in a mouse model of breast cancer | |
| Zhou et al. | Circular RNA-regulated autophagy is involved in cancer progression | |
| Pan et al. | Cudraflavone B induces human glioblastoma cells apoptosis via ER stress-induced autophagy | |
| CN111905101A (zh) | 一种cd47抗体联合il-6细胞因子药在肿瘤治疗中的应用及验证其治疗肿瘤的方法 | |
| US20240299356A1 (en) | Development of prmt-targeting therapy to enhance egfr-targeting drug efficacy in nsclc | |
| Huang et al. | Preconditioning chemotherapy with paclitaxel and cisplatin enhances the antitumor activity of cytokine induced‐killer cells in a murine lung carcinoma model | |
| US20200199681A1 (en) | Mda-7 cancer therapies and methods of detecting biomolecules |